Table 2.
Insulin sensitivity and measures of insulin metabolism.
| Whole group |
Males |
Females |
||||
|---|---|---|---|---|---|---|
| SFA | SFA + LC n-3 PUFA | SFA | SFA + LC n-3 PUFA | SFA | SFA + LC n-3 PUFA | |
| SI (mg · min−1 · kg−1 FFM) | 8.33 ± 0.50 | 8.58 ± 0.42 | 8.51 ± 0.53 | 9.41 ± 0.56* | 8.16 ± 0.86 | 7.74 ± 0.47 |
| Insulin | ||||||
| Fasting (pM) | 89.5 ± 10.3 | 79.7 ± 8.6 | 92.7 ± 16.7 | 78.7 ± 13.5 | 86.4 ± 12.8 | 80.6 ± 11.5 |
| iAUC (μM/L × 240 min) | 7.61 ± 1.06 | 8.21 ± 1.63 | 6.86 ± 1.43 | 7.55 ± 2.70 | 8.35 ± 1.59 | 8.87 ± 1.93 |
| C-peptide | ||||||
| Fasting (pM) | 503 ± 36.5 | 476 ± 37.8 | 463 ± 43.2 | 419 ± 37.1 | 542 ± 58.5 | 532 ± 63.4 |
| iAUC (μM/L × 240 min) | 38.0 ± 5.7 | 31.3 ± 6.1 | 34.8 ± 7.0 | 32.7 ± 8.2 | 41.2 ± 9.1 | 29.8 ± 9.4 |
| C-peptide: insulin ratio | ||||||
| Fasting | 7.1 ± 0.9 | 7.7 ± 1.1 | 6.6 ± 1.5 | 7.1 ± 1.3 | 7.7 ± 1.2 | 8.4 ± 1.9 |
| iAUC | −207 ± 119 | −393 ± 181 | −243 ± 222 | −239 ± 195 | −172 ± 100 | −546 ± 309 |
Data are presented as mean ± SEM; SI, insulin sensitivity. A significant difference from SFA is notated by * (P < 0.05). Outcome measures were available for a minimum of twelve males and twelve females.